Upon completion of this activity, participants will: Recognize the long-term burden of uncontrolled asthma Analyze the efficacy of biologics in reducing asthma exacerbations in patients with moderate to severe asthma Evaluate the relationship between asthma phenotypes and disease severity to guide personalized treatment recommendations Assess asthma severity to support appropriate referral Identify patients who could benefit from biologic therapy for moderate to severe asthma.
In this series of bite-sized video chapters, experts provide insight on strategies and advances in the management of severe asthma.
CME Disclosure: https://www.medscape.org/viewarticle/1002392
All Credits Available
Physicians
Maximum of 0.50 AMA PRA Category 1 Credit(s)™
Nurses
0.50 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
IPCE
0.50 Interprofessional Continuing Education (IPCE) credit
CME / CE Released: 3/26/2025
Valid for credit through: 3/26/2026, 11:59 PM EST
| Contributor | Sabah F. Iqbal, MD; Monica Kraft, MD; Charles Vega, MD |
|---|---|
| Date Content Reviewed | April 2025 |
| Future Review Date | March 2026 |
| Format | Activity |
| Length | 1 hour |
| Publication Date | 3/31/2025 |
| Source | Medscape |
